These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 38663915)

  • 1. Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Li Z; Chen Z; Shi W; Xu Y; Huang Z; Lin Z; Dou R; Lin S; Jiang X; Li M; Jiang S
    Aging (Albany NY); 2024 Apr; 16(8):6809-6838. PubMed ID: 38663915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer.
    Ou Y; Xia C; Ye C; Liu M; Jiang H; Zhu Y; Yang D
    Ann Med; 2024 Dec; 56(1):2398195. PubMed ID: 39221762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the immune landscape and drug prediction of an M2 tumor-associated macrophage-related gene signature in EGFR-negative lung adenocarcinoma.
    Huang Y; Zhang Y; Duan X; Hou R; Wang Q; Shi J
    Thorac Cancer; 2024 Jul; 15(21):1626-1637. PubMed ID: 38886907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness.
    Li X; Zheng C; Xue X; Wu J; Li F; Song D; Li X
    Funct Integr Genomics; 2023 Apr; 23(2):115. PubMed ID: 37010617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H; Chen Y; Niu H; Li X; Gai X; Cui G
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting prostate Cancer: Single-Cell insight into Macrophage Diversity, molecular Prognosticators, and the role of Peptidylprolyl Isomerase F.
    Guan B; Huang C; Meng L; Zhang S; Liu Q; Wang X; Li X; Hao Z
    Int Immunopharmacol; 2024 Sep; 138():112599. PubMed ID: 38959543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization.
    Yu G; Corn PG; Mak CSL; Liang X; Zhang M; Troncoso P; Song JH; Lin SC; Song X; Liu J; Zhang J; Logothetis CJ; Melancon MP; Panaretakis T; Wang G; Lin SH
    Proc Natl Acad Sci U S A; 2024 Aug; 121(33):e2402903121. PubMed ID: 39102549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing reveals aberrant sphingolipid metabolism in non-small cell lung cancer impacts tumor-associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling.
    Shen L; Liu J; Hu F; Fang Y; Wu Y; Zhao W; Ma S
    Thorac Cancer; 2024 May; 15(14):1164-1175. PubMed ID: 38587042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular Communication-Related Molecular Subtypes and a Gene Signature Identified by the Single-Cell RNA Sequencing Combined with a Transcriptomic Analysis.
    Guan P; Cai W; Wu K; Jiang F; Wu J; Zhai X; Zeng M
    Dis Markers; 2022; 2022():6837849. PubMed ID: 35620271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
    Lin S; Dai Y; Han C; Han T; Zhao L; Wu R; Liu J; Zhang B; Huang N; Liu Y; Lai S; Shi J; Wang Y; Lou M; Xie J; Cheng Y; Tang H; Yao H; Fang H; Zhang Y; Wu X; Shen L; Ye Y; Xue L; Wu ZB
    Genome Med; 2024 Apr; 16(1):60. PubMed ID: 38658971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
    Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer.
    Wen XY; Wang RY; Yu B; Yang Y; Yang J; Zhang HC
    Sci Rep; 2023 Sep; 13(1):15597. PubMed ID: 37730847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Bulk and Single-Cell RNA Sequencing Reveals Heterogeneity, Tumor Microenvironment, and Immunotherapeutic Efficacy Based on Sialylation-Related Genes in Bladder Cancer.
    Tan Z; Chen X; Zuo J; Fu S; Wang J; Wang H
    J Inflamm Res; 2023; 16():3399-3417. PubMed ID: 37600224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
    Meyer-Siegler KL; Iczkowski KA; Leng L; Bucala R; Vera PL
    J Immunol; 2006 Dec; 177(12):8730-9. PubMed ID: 17142775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor mediates skin aging via CD74: Insights from single-cell and bulk RNA sequencing data.
    Wu S; Ouyang Y; Hu Y; Jiang L; Fu C; Lei L; Zhang Y; Guo H; Huang J; Chen J; Zeng Q
    Clin Immunol; 2024 Jun; 263():110199. PubMed ID: 38565329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.